Differential Therapy for Diffuse Large B-Cell Lymphoma with Different Cells of Origin

Publisher： Karger

E-ISSN： 2296-5262|32|12|711-712

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.12, 2009-11, pp. : 711-712

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B‐cell lymphoma in the rituximab era

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 776-783

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and Clinical Significance of Aberrant T-Cell Marker Expression on Diffuse Large B-Cell Lymphoma Cells

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-06 ,pp. : 230-237

Karger

Access to resources Recommend Favorite

The Effect of Biweekly CHOP and Standard CHOP in Different Subgroups of Diffuse Large B-Cell Lymphoma

By  

Oncology Research and Treatment, Vol. 32, Iss. 12, 2009-11 ,pp. : 719-723

Karger

Access to resources Recommend Favorite

Primary diffuse large B‐cell lymphoma of the testis relapsing in the right atrium

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 4, 2015-02 ,pp. : 469-469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management strategies in patients with diffuse large B‐cell lymphoma and severe haemophilia

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : e445-e447

John Wiley & Sons Inc

Access to resources Recommend Favorite